https://www.oncologynurseadvisor.com Wed, 17 Jan 2024 20:06:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/genitourinary-cancer/atezolizumab-chemo-did-not-improve-os-advanced-urothelial-cancer/ Wed, 17 Jan 2024 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=115985 https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/adenocarcinoma-now-the-most-common-type-of-lung-cancer-worldwide/ Fri, 03 Nov 2023 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=113777 Adenocarcinoma has become the most common subtype of lung cancer, according to data from 14 world regions.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/cancer-drug-shortages-persist-increasing-calls-for-action/ Tue, 17 Oct 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=111171 As health care providers across the United States grapple with ongoing shortages of cancer drugs, experts are sounding the alarm about drugs that are becoming harder to obtain.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/cisplatin-shortage-nearly-resolved-supplies-of-carboplatin-methotrexate-increasing/ Tue, 26 Sep 2023 14:40:01 +0000 https://www.oncologynurseadvisor.com/?p=110824 The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.]]> https://www.oncologynurseadvisor.com/home/general-medicine/most-patients-surveyed-trust-an-ai-diagnosis-over-a-doctors-diagnosis/ Fri, 25 Aug 2023 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=109969 In a survey of more than 1000 people, 64% said they would trust a diagnosis made by AI over a diagnosis made by a doctor.]]> https://www.oncologynurseadvisor.com/home/cancer-types/sarcoma/pembrolizumab-produces-responses-in-some-rare-sarcomas/ Thu, 20 Jul 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=109291 Pembrolizumab yielded responses in patients with chordoma, desmoplastic small round cell tumors, epithelioid sarcoma, and other rare sarcomas. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/acalabrutinib-rituximab-highly-effective-older-mcl-patients-2/ Tue, 27 Jun 2023 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=108787 Acalabrutinib and rituximab can yield early complete responses in older patients with previously untreated mantle cell lymphoma.]]>